Want to see HK:1931 full AI Analyst Report?
1931 Stock Chart & Stats
HK$3.85
HK$0.05(2.67%)
At close: 4:00 PM EST
HK$3.85
HK$0.05(2.67%)
Day’s Range― - ―
52-Week RangeHK$0.56 - HK$11.96
Previous CloseN/A
Volume18.00K
Average Volume (3M)1.48M
Market Cap
HK$964.79M
Enterprise ValueHK$5.81K
Total Cash (Recent Filing)HK$551.05M
Total Debt (Recent Filing)HK$1.93B
Price to Earnings (P/E)23.2
Beta0.58
Next Earnings
Mar 12, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.81%
Share Statistics
EPS (TTM)0.02
Shares Outstanding1,621,488,000
10 Day Avg. Volume1,443,300
30 Day Avg. Volume1,483,483
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.29
Price to Sales (P/S)1.35
P/FCF Ratio-3.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Historical ProfitabilityThe 2021–2024 record indicates the core business previously supported healthy margins and growth. This history provides evidence of underlying operating capability, although restoring those economics depends on reversing the sharp 2025 earnings deterioration.
Prior Cash GenerationPositive operating and free cash flow across 2021–2024 shows the company has previously converted operations into cash. That track record could support a recovery if working-capital pressure and elevated cash outlays normalize, though current performance is materially weaker.
Equity BaseA sizable equity base provides some balance-sheet support and may help absorb operational volatility without immediate reliance on external financing. This cushion is a durable positive, although its protective value is reduced by rising leverage and weaker profitability.
Bears Say
Revenue And Margin DeclineThe simultaneous revenue contraction and margin compression indicate weaker demand, operating leverage, or competitive economics. Unless reversed, this earnings reset can reduce reinvestment capacity and make sustainable shareholder returns materially harder to achieve.
Negative Cash FlowThe sharp cash-flow reversal creates a fundamental funding risk because operations no longer cover ongoing cash needs. Persistent working-capital pressure or heavier outlays could require additional borrowing or other financing, limiting strategic flexibility.
Rising LeverageThe sharp increase in debt relative to equity reduces financial flexibility just as earnings and cash generation have weakened. Higher leverage can raise refinancing dependence and constrain investment or distributions if operating conditions remain under pressure.
IVD Medical Holding Limited News
1931 FAQ
What was IVD Medical Holding Limited’s price range in the past 12 months?
IVD Medical Holding Limited lowest stock price was HK$0.56 and its highest was HK$11.96 in the past 12 months.
What is IVD Medical Holding Limited’s market cap?
IVD Medical Holding Limited’s market cap is HK$964.79M.
When is IVD Medical Holding Limited’s upcoming earnings report date?
IVD Medical Holding Limited’s upcoming earnings report date is Mar 12, 2027 which is in 204 days.
How were IVD Medical Holding Limited’s earnings last quarter?
Currently, no data Available
Is IVD Medical Holding Limited overvalued?
According to Wall Street analysts IVD Medical Holding Limited’s price is currently Overvalued.
Does IVD Medical Holding Limited pay dividends?
IVD Medical Holding Limited pays a Notavailable dividend of HK$0.062 which represents an annual dividend yield of 3.81%. See more information on IVD Medical Holding Limited dividends here
What is IVD Medical Holding Limited’s EPS estimate?
IVD Medical Holding Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IVD Medical Holding Limited have?
IVD Medical Holding Limited has 1,621,488,000 shares outstanding.
What happened to IVD Medical Holding Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IVD Medical Holding Limited?
Currently, no hedge funds are holding shares in HK:1931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IVD Medical Holding Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
320.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
12.45%
Trailing 12-Months
Company Description
IVD Medical Holding Limited
null
Technical Analysis
China Health Group
―
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―